| D55 | 'For me, it is my faith that helps me': interface of faith and health for women living with disabilities and HIV in Port Harcourt and Uyo, South-South Nigeria | E-poster | Qualitative and ethnographic methods in HIV research |
| D55 | Alien time capsules an online participatory- and arts-based research method for COVID-19 research with HIV-affected South African adolescents and young people | E-poster | Qualitative and ethnographic methods in HIV research |
| D55 | A mile in our shoes - transect walk community mapping for design of a youth sexual and reproductive health intervention in Chitungwiza, Zimbabwe | E-poster | Qualitative and ethnographic methods in HIV research |
| D45 | The impact of HIV stigma on time to art initiation in four African countries | E-poster | Reduction of socio-structural barriers and stigma discrimination |
| D45 | Implementing a patient satisfaction survey to identify factors responsible for missed appointments amongst PLHIVs in Nigeria | E-poster | Reduction of socio-structural barriers and stigma discrimination |
| B35 | Comparison of viral replication for the 2-drug regimen (2DR) of dolutegravir/lamivudine (DTG/3TC) versus a 3/4-drug tenofovir alafenamide'based regimen (TBR) in the TANGO study through week 96 | On-demand oral abstract session | Regimen simplification and switch studies |
| B35 | Prevalence of baseline virological risk factors of increased virological failure to CAB+RPV among ARV-naïve patients | On-demand oral abstract session | Regimen simplification and switch studies |
| B35 | APOBEC editing in HIV DNA proviral vif and pol long-reads issued from virologically-suppressed patients included in the ANRS LAMIDOL trial | On-demand oral abstract session | Regimen simplification and switch studies |
| B35 | Switching to the 2-drug regimen of dolutegravir/lamivudine (DTG/3TC) fixed-dose combination (FDC) is non-inferior to continuing a 3-drug regimen through 24 weeks in a randomized clinical trial (SALSA) | Oral abstract session with live Q&A | Regimen simplification and switch studies |
| B35 | Bictegravir/emtricitabine/tenofovir alafenamide in patients with genotypic NRTI resistance | E-poster | Regimen simplification and switch studies |